Literature DB >> 29804476

Esophageal achalasia: current diagnosis and treatment.

Francisco Schlottmann1, Marco G Patti2.   

Abstract

INTRODUCTION: Esophageal achalasia is a primary esophageal motility disorder of unknown origin, characterized by lack of peristalsis and by incomplete or absent relaxation of the lower esophageal sphincter in response to swallowing. The goal of treatment is to eliminate the functional obstruction at the level of the gastroesophageal junction. Areas covered: This comprehensive review will evaluate the current literature, illustrating the diagnostic evaluation and providing an evidence-based treatment algorithm for this disease. Expert commentary: Today, we have three very effective therapeutic modalities to treat patients with achalasia - pneumatic dilatation, peroral endoscopic myotomy, and laparoscopic Heller myotomy with fundoplication. Treatment should be tailored to the individual patient, in centers where a multidisciplinary approach is available. Esophageal resection should be considered as a last resort for patients who have failed prior therapeutic attempts.

Entities:  

Keywords:  Dor fundoplication; Esophageal achalasia; Heller myotomy; dysphagia; esophageal manometry; per oral endoscopic myotomy; pneumatic dilatation

Mesh:

Year:  2018        PMID: 29804476     DOI: 10.1080/17474124.2018.1481748

Source DB:  PubMed          Journal:  Expert Rev Gastroenterol Hepatol        ISSN: 1747-4124            Impact factor:   3.869


  13 in total

1.  Esophageal achalasia after Roux-en-Y gastric bypass for morbid obesity.

Authors:  María A Casas; Francisco Schlottmann; Fernando A M Herbella; Rudolf Buxhoeveden; Marco G Patti
Journal:  Updates Surg       Date:  2019-11-05

Review 2.  Esophageal Dysfunction in Post-lung Transplant: An Enigma.

Authors:  Aditya V Jadcherla; Kevin Litzenberg; Gokulakrishnan Balasubramanian
Journal:  Dysphagia       Date:  2022-08-12       Impact factor: 2.733

3.  Robotic redo Heller myotomy: how I do it?

Authors:  Antonio Cubisino; Francisco Schlottmann; Nicolas H Dreifuss; Carolina Baz; Alberto Mangano; Mario A Masrur; Francesco M Bianco; Pier Cristoforo Giulianotti
Journal:  Langenbecks Arch Surg       Date:  2022-05-18       Impact factor: 2.895

4.  Widening of the mediastinum.

Authors:  Edson Marchiori; Bruno Hochhegger; Gláucia Zanetti
Journal:  J Bras Pneumol       Date:  2022-06-10       Impact factor: 2.800

Review 5.  The Evolution of the Treatment of Esophageal Achalasia: From the Open to the Minimally Invasive Approach.

Authors:  Francisco Schlottmann; Fernando A M Herbella; Marco G Patti
Journal:  World J Surg       Date:  2022-02-15       Impact factor: 3.282

Review 6.  Surgical management of achalasia.

Authors:  Kamil Nurczyk; Marco G Patti
Journal:  Ann Gastroenterol Surg       Date:  2020-05-25

7.  Influence of esophageal morphology on the clinical efficacy of peroral endoscopic myotomy in treating advanced achalasia cardia.

Authors:  Dan Liu; Yue-Yuan Liu; Jia-Xin Chen; Lei Song; Yang-Yang Zhou; Saif Ullah; Li-Xia Zhao; Bin Hai; Qing-Fen Zheng; Dong-Ying Li; De-Zhi He; Bing-Rong Liu
Journal:  Exp Ther Med       Date:  2021-01-08       Impact factor: 2.447

8.  Simultaneous coronary artery disease and achalasia surgery: A novel approach.

Authors:  Rimantas Benetis; Algimantas Budrikis; Jonas Gazdziauskas
Journal:  Turk Gogus Kalp Damar Cerrahisi Derg       Date:  2021-10-20       Impact factor: 0.332

9.  A New Preparation Method for Peroral Endoscopic Myotomy in Patients with Achalasia Can Effectively Reduce the Esophageal Residual Contents: A Comparative Retrospective Study.

Authors:  Zehua Zhang; Xiaohan Yan; Bensong Duan; Zhuyun Leng; Haibin Zhang; Jinze Li; Yinghua Zhu; Meidong Xu; Qinwei Xu
Journal:  Gastroenterol Res Pract       Date:  2022-02-03       Impact factor: 2.260

10.  Scoping Review and Bibliometric Analysis of the Most Influential Publications in Achalasia Research from 1995 to 2020.

Authors:  Huifang Xia; Shali Tan; Shu Huang; Peiling Gan; Chunyu Zhong; Muhan Lü; Yan Peng; Xian Zhou; Xiaowei Tang
Journal:  Biomed Res Int       Date:  2021-02-04       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.